Osaic Holdings’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,603
| Closed | -$25.2K | – | 7686 |
|
|
2024
Q1 | $25.2K | Sell |
1,603
-1,433
| -47% | -$22.1K | ﹤0.01% | 5210 |
|
|
2023
Q4 | $48.9K | Sell |
3,036
-215
| -7% | -$2.74K | ﹤0.01% | 4922 |
|
|
2023
Q3 | $41.3K | Buy |
3,251
+317
| +11% | +$4.37K | ﹤0.01% | 5116 |
|
|
2023
Q2 | $41.3K | Buy |
2,934
+197
| +7% | +$2.82K | ﹤0.01% | 5061 |
|
|
2023
Q1 | $42.3K | Sell |
2,737
-1,594
| -37% | -$26.6K | ﹤0.01% | 5066 |
|
|
2022
Q4 | $71.1K | Buy |
4,331
+1,898
| +78% | +$30.9K | ﹤0.01% | 4683 |
|
|
2022
Q3 | $45K | Buy |
2,433
+100
| +4% | +$1.57K | ﹤0.01% | 5004 |
|
|
2022
Q2 | $30K | Hold |
2,333
| – | – | ﹤0.01% | 5346 |
|
|
2022
Q1 | $22K | Buy |
2,333
+58
| +3% | +$493 | ﹤0.01% | 5642 |
|
|
2021
Q4 | $22K | Sell |
2,275
-2,690
| -54% | -$50.6K | ﹤0.01% | 5739 |
|
|
2021
Q3 | $169K | Buy |
4,965
+532
| +12% | +$17K | ﹤0.01% | 4064 |
|
|
2021
Q2 | $162K | Buy |
4,433
+1,068
| +32% | +$41.4K | ﹤0.01% | 4051 |
|
|
2021
Q1 | $151K | Buy |
3,365
+2,820
| +517% | +$131K | ﹤0.01% | 4005 |
|
|
2020
Q4 | $32K | Hold |
545
| – | – | ﹤0.01% | 4873 |
|
|
2020
Q3 | $29K | Buy |
545
+429
| +370% | +$21K | ﹤0.01% | 4693 |
|
|
2020
Q2 | $7K | Sell |
116
-582
| -83% | -$31.1K | ﹤0.01% | 5356 |
|
|
2020
Q1 | $24K | Buy |
+698
| New | +$38.8K | ﹤0.01% | 4516 |
|
Other funds holding DCPH
Osaic Holdings's DCPH Position: Q2 2024 in Review
Osaic Holdings sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 1,603 shares — an estimated $25.2K sold.
Osaic Holdings first reported a position in DCPH in Q1 2020 and held it in 17 quarters. The position peaked at $169K in Q3 2021. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Osaic Holdings reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Osaic Holdings sold 1,603 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $25.2K.
- Osaic Holdings first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 17 quarters.
- Osaic Holdings's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $169K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Osaic Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.